Contrast enhanced ultrasound (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 96 | クローン病 | 4 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04660136 (ClinicalTrials.gov) | December 1, 2020 | 2/12/2020 | Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn's Disease Pediatric Patients | Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn's Disease Pediatric Patients | Crohn's Disease in Pediatric Patient | Biological: contrast enhanced ultrasound | Yonsei University | NULL | Recruiting | 2 Years | 18 Years | All | 20 | Phase 4 | Korea, Republic of |
| 2 | NCT03492944 (ClinicalTrials.gov) | March 6, 2020 | 12/2/2018 | Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason | Contrast-Enhanced Ultrasound Evaluation of Bowel Wall Inflammation in Pediatric Crohn's Disease: Comparison to CT and MRI Enterography | Crohn Disease | Drug: Ultrasound Microbubble Contrast Agent;Device: Ultrasound Imaging | Children's Hospital Medical Center, Cincinnati | NULL | Recruiting | 10 Years | 18 Years | All | 25 | United States | |
| 3 | NCT02061163 (ClinicalTrials.gov) | February 2015 | 6/2/2014 | Contrast-Enhanced Ultrasound in Human Crohn's Disease | Evaluation of Contrast-Enhanced Ultrasound in Human Crohn's Disease | Crohn's Disease | Device: Contrast Enhanced Ultrasound;Drug: Optison | University of Michigan | NULL | Withdrawn | 10 Years | N/A | Both | 0 | Phase 1;Phase 2 | United States |
| 4 | EUCTR2015-002882-41-AT (EUCTR) | 05/11/2015 | A Pilot Study on the use of contrast enhanced ultrasound in Crohn’s disease | Sono-Response-StudyA Pilot Study on the use of contrast enhanced ultrasound in Crohn’s disease | Inflammatory bowel disease (Crohn's disease) MedDRA version: 18.1;Level: PT;Classification code 10011401;Term: Crohn's disease;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] | Trade Name: SonoVue Product Name: SonoVue INN or Proposed INN: sulphur hexafluoride Other descriptive name: SULFUR HEXAFLUORIDE | Medical University of Vienna (MUW) | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Austria |